University of Pittsburgh
Dr. Kanhaiya Singh is an Associate Professor at the Department of Surgery, University of Pittsburgh. Dr. Singh received his doctoral degree in Biotechnology from Banaras Hindu University, India. Prior to joining University of Pittsburgh, Dr. Singh served as an Assitant Professor at Indiana University. His research focus is on epigenetic mechanisms of gene expression during diabetic vasculopathy and includes single-cell transcriptomics and single-cell ATAC sequencing approaches to investigate the molecular pathways that are compromised. His laboratory is also investigating the epigenetic mechanisms such as DNA methylation as a proxy for abnormal gene–environmental interactions in diabetic ischemic wounds. Current line of study aims to develop a simple and point of care approach to achieve targeted epigenetic editing of adult diabetic ischemic tissue in vivo. To that end, his team is employing Tissue Nanotransfection (TNT) technology as a delivery platform to administer combination gene therapy for diabetic ischemic tissue rescue. This research is funded through peer-reviewed grants from Department of Defense (DoD) and NIH-NIDDK. Dr. Singh has authored more than 50 peer reviewed publications. Dr Singh has been an Editorial Boards peer reviewed journals such as Scientific Reports, Plos One, Frontiers in Endocrinology and Heliyon. In this role, he has edited more than 200 publications and 4 special issues. He serves as active member of Wound Healing Society and American Diabetes Association.
Disclosure information not submitted.
Sunday, November 5, 2023
9:10 AM – 10:10 AM PDT